<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen W</submitter><funding>Intramural NIH HHS</funding><pagination>1021-1030</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11345751</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(7)</volume><pubmed_abstract>Interleukin-33 (IL-33), an epithelial cell-derived cytokine that responds rapidly to environmental insult, has a critical role in initiating airway inflammatory diseases. However, the molecular mechanism underlying IL-33 secretion following allergen exposure is not clear. Here, we found that two cell events were fundamental for IL-33 secretion after exposure to allergens. First, stress granule assembly activated by allergens licensed the nuclear-cytoplasmic transport of IL-33, but not the secretion of IL-33. Second, a neo-form murine amino-terminal p40 fragment gasdermin D (Gsdmd), whose generation was independent of inflammatory caspase-1 and caspase-11, dominated cytosolic secretion of IL-33 by forming pores in the cell membrane. Either the blockade of stress granule assembly or the abolishment of p40 production through amino acid mutation of residues 309-313 (ELRQQ) could efficiently prevent the release of IL-33 in murine epithelial cells. Our findings indicated that targeting stress granule disassembly and Gsdmd fragmentation could reduce IL-33-dependent allergic airway inflammation.</pubmed_abstract><journal>Nature immunology</journal><pubmed_title>Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion.</pubmed_title><pmcid>PMC11345751</pmcid><funding_grant_id>ZIA AI001169</funding_grant_id><pubmed_authors>Zhang D</pubmed_authors><pubmed_authors>Long G</pubmed_authors><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Lu X</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Sun B</pubmed_authors><pubmed_authors>Jiang H</pubmed_authors><pubmed_authors>Fu Y</pubmed_authors><pubmed_authors>Wu B</pubmed_authors><pubmed_authors>Wu D</pubmed_authors><pubmed_authors>Zhang R</pubmed_authors><pubmed_authors>Iv H</pubmed_authors><pubmed_authors>Chen W</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Fan W</pubmed_authors><pubmed_authors>Chen M</pubmed_authors><pubmed_authors>Lv D</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Zhong S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Zhu L</pubmed_authors><pubmed_authors>Yan C</pubmed_authors><pubmed_authors>Ling Z</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion.</name><description>Interleukin-33 (IL-33), an epithelial cell-derived cytokine that responds rapidly to environmental insult, has a critical role in initiating airway inflammatory diseases. However, the molecular mechanism underlying IL-33 secretion following allergen exposure is not clear. Here, we found that two cell events were fundamental for IL-33 secretion after exposure to allergens. First, stress granule assembly activated by allergens licensed the nuclear-cytoplasmic transport of IL-33, but not the secretion of IL-33. Second, a neo-form murine amino-terminal p40 fragment gasdermin D (Gsdmd), whose generation was independent of inflammatory caspase-1 and caspase-11, dominated cytosolic secretion of IL-33 by forming pores in the cell membrane. Either the blockade of stress granule assembly or the abolishment of p40 production through amino acid mutation of residues 309-313 (ELRQQ) could efficiently prevent the release of IL-33 in murine epithelial cells. Our findings indicated that targeting stress granule disassembly and Gsdmd fragmentation could reduce IL-33-dependent allergic airway inflammation.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jul</publication><modification>2025-04-21T15:26:28.337Z</modification><creation>2025-04-21T15:26:28.337Z</creation></dates><accession>S-EPMC11345751</accession><cross_references><pubmed>35794369</pubmed><doi>10.1038/s41590-022-01255-6</doi></cross_references></HashMap>